feed
S&P 500
NASDAQ
DOW
RUSSELL
VIX
US10Y
DXY
EUR/USD
GBP/USD
GOLD
WTI
BTC
ETH
AArphra

VRTX

Vertex Pharmaceuticals Incorporated
HealthcareBiotechnologyUSUSD
$447.54
+0.50%Live · FMPMay 29, 2026
AI Brief
Market cap
$113.59B
52w range
362.50 – 507.92
P / E
EPS
Volume
1.89M
Revenue · FY
$12.07B
+9.57% YoY

Stock splits

DB · stock_splits1
DateRatioTypeMultiplier
Aug 24, 20002-for-1Forward2.00×

M&A activity

1DB · FMP /mergers-acquisitions

Whole-company transactions where VRTX is acquirer or target.

DateRoleCounterpartyFiling
May 23, 2001AcquirerAuroraSEC →

Beneficial-ownership filings

DB · 13D/G8
FiledFormReporter% ownedShares
Jan 25, 2024(1) BlackRock, Inc.8.50%SEC →
Feb 13, 202395-14110375.00%SEC →
Feb 09, 2023FMR LLC6.96%SEC →
Feb 09, 2023Abigail P. Johnson6.96%SEC →
Jan 24, 2023(1) BlackRock, Inc.9.40%SEC →
Feb 14, 202252-05569482.10%SEC →
Feb 10, 2022The Vanguard Group - 23-19459307.93%SEC →
Feb 01, 2022(1) BlackRock, Inc.9.40%SEC →

Corporate actions combine splits (live, full history), symbol changes (refreshed weekly), the daily M&A wire, and 13D/G filings.